What 浙江华润三九众益制药有限公司 does

浙江华润三九众益制药有限公司 (Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Co., Ltd.) is a small China-based pharmaceutical entity headquartered in Lishui, Zhejiang Province. The corporate name indicates an affiliation with China Resources Sanjiu (华润三九), a major state-owned Chinese pharmaceutical group, though the input data does not confirm the parent-subsidiary relationship, ownership stake, or operational linkage. The entity reports a headcount of 13 employees and its listed web address (http://zhypharm.com/) returns a 404 error, indicating that the primary corporate web presence is currently inaccessible or has been removed.

No product portfolio, therapeutic areas, manufacturing capacity, distribution channels, customer segments, or pricing information is present in the available source data. The company profile is empty across technology, products, customers, partnerships, leadership, certifications, funding, and regulatory dimensions. As a result, the entity's specific business function — whether it operates as a manufacturing site, a regional distribution arm, a contract development organization, an R&D shell, or a dormant holding vehicle — cannot be verified from the input. The description is intentionally narrow to avoid inferring scope, scale, or commercial activity beyond what the firmographic record supports.

The fundamental data gap is material: the absence of a functional website, the lack of any disclosed products or customers, a 13-person headcount, and the absence of any external signals (news, funding, regulatory filings, partnerships) collectively imply either a highly localized/non-promotional operating entity, a transitional corporate structure, or a dormant subsidiary. Any downstream investment, M&A, or partnership analysis would require primary-source diligence (corporate registration filings, parent-group disclosures, and direct management inquiry) to confirm operating status, revenue contribution, and strategic role within the broader China Resources Sanjiu group.

Name

浙江华润三九众益制药有限公司

Website

https://zhypharm.com

Company type

Private

Operating status

Operating

Short description

浙江华润三九众益制药有限公司 is a small (13-employee) pharmaceutical entity based in Lishui, Zhejiang Province, China, whose name indicates affiliation with the China Resources Sanjiu (华润三九) group. No products, customers, or business model details are disclosed in available sources.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

Keywords

• Pharmaceutical manufacturing
• Generic drug production
• Oral solid dosage forms
• Finished dosage formulations
• Pharmaceutical tablets

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Infrastructure

Core offering

Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Co., Ltd. (浙江华润三九众益制药有限公司) is a pharmaceutical manufacturer based in Lishui City, Zhejiang Province, China. Operating as a small-scale production entity with approximately 13 employees, the company is positioned as a manufacturing arm within the China Resources Sanjiu (华润三九) pharmaceutical group, focused on finished pharmaceutical dosage production.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Expansion highlights4 records

Broad incumbents

• China Resources Sanjiu Medical & Pharmaceutical (华润三九): Major Chinese branded pharmaceutical and OTC manufacturer with strong TCM and chemical drug portfolios. Comparable as the apparent parent/affiliated entity and the most relevant reference point for evaluating this subsidiary's strategic role within the CR Sanjiu ecosystem.
• Zhejiang Huahai Pharmaceutical (浙江华海药业): Zhejiang-based generic pharmaceutical manufacturer specializing in finished dosage forms and APIs with strong export focus. Comparable as a Zhejiang-headquartered generic drug manufacturer with similar regulatory and manufacturing profile.
• Yangtze River Pharmaceutical Group (扬子江药业): One of China's largest privately-held pharmaceutical manufacturers focused on generic finished dosage forms across multiple therapeutic areas. Comparable as a Chinese generic FDF manufacturer operating in overlapping categories.
• Harbin Pharmaceutical Group (哈药集团): Large Chinese pharmaceutical group producing branded and generic finished dosage forms including tablets, capsules, and injectables. Comparable as a major Chinese generic drug manufacturer with broad product portfolio.
• Livzon Pharmaceutical Group (丽珠医药): Chinese pharmaceutical manufacturer producing chemical drugs, biologics, and TCM products in finished dosage forms. Comparable as a multi-category Chinese pharma manufacturer with generic and specialty products.

Regional players

• Zhejiang Conba Pharmaceutical (浙江康恩贝制药): Zhejiang-based pharmaceutical company producing TCM and chemical drugs in finished dosage forms. Comparable as a regionally-headquartered Chinese pharma manufacturer operating in the same geography.
• Apeloa Pharmaceutical (浙江普洛药业): Zhejiang-based pharmaceutical manufacturer producing APIs and finished dosage forms for domestic and international markets. Comparable as a Zhejiang pharma manufacturer with integrated API-FDF capabilities.

Market position

Strengths2 records

Weaknesses3 records

Competitive moat1 record

Key risks4 records

Key highlights3 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 浙江华润三九众益制药有限公司